Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
JWK-004 by Chengdu Genevector Biotechnology for Hemophilia B (Factor IX Deficiency): Likelihood of Approval
JWK-004 is under clinical development by Chengdu Genevector Biotechnology and currently in Phase I for Hemophilia B (Factor IX Deficiency)....